aDivision of Translational Therapeutics, Department of
Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, BC,
Canada
bNiigata University Graduate School of Medical and Dental
Sciences, Niigata, Japan
cStevens-Johnson Syndrome Foundation, Westminster, CO,
USA
dFaculty of Medicine, University of Southampton, Southampton
General Hospital, Southampton, UK
eWilford Hall Ambulatory Surgical Center, Lackland Air Force
Base, TX, USA
fDrug Hypersensitivity Group. Hospital La Paz Institute for
Health Research (IdiPAZ), Madrid, Spain
gLoyola University Medical Center, Chicago, IL, USA
hSchool of Pharmacy and Molecular and Cellular Therapeutics,
Royal College of Surgeons in Ireland, Dublin, Ireland
iSJS Awareness Oregon, Klamath Falls, OR, USA
jMassachusetts Eye and Ear, Harvard Medical School, Boston,
MA, USA
kDivision of Rheumatology, Allergy and Immunology,
Massachusetts General Hospital, Boston, MA, USA
lNational Institute of Arthritis and Musculoskeletal and
Skin Diseases, NIH, USA
mDepartment of Dermatology, Brigham and Women’s
Hospital, Harvard Medical School, Boston, MA, USA
nGenome Canada, Ottawa, ON, Canada
oDepartment of Obstetrics and Gynecology, University of
British Columbia, Vancouver, BC, Canada
pDepartment of Ophthalmology and Visual Sciences,
University of British Columbia, Vancouver, BC, Canada
qCanadian Institutes of Health Research, Ottawa, ON,
Canada
rDepartment of Obstetrics and Gynecology, University of
Washington, Seattle, WA, USA
sChildren’s Mercy Hospital Kansas City, Kansas City,
MO, USA
tWake Forest University School of Medicine, WFBMC Burn
Center, Winston-Salem, NC, USA
uGenome British Columbia, Vancouver, BC, Canada
vCancer Vaccine and Immune Cell Therapy Core Laboratory,
Chang Gung Immunology Consortium, Chang Gung Memorial Hospital, Linkou, Taoyuan,
Taiwan
wEden Social Welfare Foundation, Taipei, Taiwan
xDepartment of Ophthalmology and Visual Sciences,
University of British Columbia, Vancouver General Hospital Eye Care Center,
Vancouver, BC, Canada
yDepartment of Ophthalmology, Seoul National University
College of Medicine, Seoul, South Korea
zDepartment of Medicine, University of Washington, Seattle,
WA, USA
aaMemorial Sloan Kettering Cancer Center, New York, NY,
USA
abAssociation des malades des syndromes de Lyell et de
Stevens-Johnson (Amalyste), Paris, France
acDivision of Dermatology, Department of Medicine,
University of Cape Town, Cape Town, South Africa
adHealth Products and Food Branch, Health Canada, Ottawa,
ON, Canada
aeSJS/TEN International Awareness (STIA), Lucky Lake, SK,
Canada
afDepartment of Dermatology, Perelman School of Medicine,
University of Pennsylvania, Philadelphia, PA, USA
agDokumentationszentrum schwerer Hautreaktionen (dZh),
Department of Dermatology, Medical Center and Medical Faculty, University of
Freiburg, Freiburg, Germany
ahSJ Syndrome of Texas, Austin, TX, USA
aiLaboratory of Immunology, Division of Biotechnology
Review and Research III (DBRR III), Office of Biotechnology Products (OBP), Office
of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER),
FDA, Silver Spring, MD, USA
ajDivision of Dermatology, Department of Medicine,
University of Alberta, Edmonton, AB, Canada
akDepartment of Der matology, MedStar Washington Hospital
Center, Washington, DC, USA
alDivision of Allergy and Clinical Immunology, Department
of Medicine, University of Cape Town, Cape Town, South Africa
amDepartment of Molecular and Clinical Pharmacology,
University of Liverpool, Liverpool, UK
anDepartment of Paediatrics, Children’s
Hospital/London Health Sciences Centre, Schulich School of Medicine & Dentistry,
Western University, London, ON, Canada
aoSunnybrook Health Sciences Centre, University of Toronto,
ON, Canada
apDepartment of Ophthalmology, Vanderbilt Eye Institute,
Nashville, TN, USA
aqDutch Medicines Evaluation Board, Pharmacovigilance Risk
Assessment Committee, European Medicines Agency, Utrecht, Netherlands
arRamathibodi Hospital, Mahidol University, Bangkok,
Thailand
asHealth Products Regulation Group, Health Sciences
Authority Singapore, Duke-NUS Medical School, Singapore
atDepartment of Infectious Diseases, Austin Health,
Heidelberg, Germany
auDepartment of Frontier Medical Science and Technology for
Ophthalmology, Kyoto Pre fectural University of Medicine, Kyoto, Japan
avNational Human Genome Research Institute, NIH, Bethesda,
ML, USA
awInstitute of Dermatology, Chinese Academy of Medical
Sciences, National Center for STD and Leprosy Control, China CDC, Nanjing,
China
axDivision of Pharmacovigilance I, Office of Surveillance
and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug
Administration, USA
aySJS Canada, Brantford, ON, Canada
azNational Institute of Allergy and Infectious Diseases,
NIH, Bethesda, ML, USA
baDepartment of Pathology, Microbiology and Immunology,
Vanderbilt University Medical Center, Nashville, TN, USA
bbDivision of General Internal Medicine and Primary Care,
Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
bcDepartment of Dermatology, Drug Hypersensitivity Clinical
and Research Center, Chang Gung Memorial Hospital, Linkou, Taipei, Keelung, Taoyuan,
Taiwan
bdCancer Vaccine and Immune Cell Therapy Core Laboratory,
Chang Gung Immunology Consortium, Chang Gung Memorial Hospital, Linkou, Taoyuan,
Taiwan
beCollege of Medicine, Chang Gung University, Taoyuan,
Taiwan
bfWhole-Genome Research Core Laboratory of Human Diseases,
Chang Gung Memorial Hospital, Keelung, Taiwan
bgInstitute for Immunology and Infectious Diseases, Murdoch
University, Murdoch, Australia
bhDivision of Infectious Diseases, Department of Medicine,
Vanderbilt University Medical Center, Nashville, TN, USA
biDepartment of Pharmacology, Vanderbilt University Medical
Center, Nashville, TN, USA
bjFutureNeuro SFI Research Centre, Royal College of
Surgeons in Ireland, Dublin, Ireland
bkBritish Columbia Children’s Hospital Research
Institute, Vancouver, BC, Canada
blInstitute of Pharmacology, National Yang-Ming University,
Taipei, Taiwan
bmDepartment of Medicine, University of Melbourne,
Victoria, Australia
bnDepartment of Dermatology, Xiamen Chang Gung Hospital,
Xiamen, China
1Co-chairs of meeting contributed equally to publication.
✉bcarleton@popi.ubc.ca (B.C. Carleton).
